An Exploratory Review on the Hypoglycemic Action of Unani Anti-diabetic Drugs via Possible Modulation of Gut Microbiota
CONCLUSION: This is the first study on the integrative strategy about the hypoglycemic effects of Unani herbs that could serve as a prerogative novel approach for cost-effective, holistic, rationalistic, and multi-targeted diabetes management.PMID:38115618 | DOI:10.2174/0113894501275731231215101426 (Source: Current Drug Targets)
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Shaheen Akhlaq Shabnam Anjum Ara Malik Itrat Mohammad Fazil Bilal Ahmad Usama Akram Merajul Haque Neelam Quddusi Ahmad Sayeed Source Type: research
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
Curr Drug Targets. 2023 Dec 19. doi: 10.2174/0113894501280380231214105255. Online ahead of print.ABSTRACTUveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor. Symptoms include blurred vision, redness of the eye, floaters, dark spots, a change in the size of the pupil, and loss of vision. The location, shape, and size of the tumor are important for therapeutic purposes. Treating me...
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Khalid Al Balushi Abdulrahman Al Hadhrami Hamdan Al Balushi Srijit Das Abdullah Al Lawati Source Type: research
An Exploratory Review on the Hypoglycemic Action of Unani Anti-diabetic Drugs via Possible Modulation of Gut Microbiota
CONCLUSION: This is the first study on the integrative strategy about the hypoglycemic effects of Unani herbs that could serve as a prerogative novel approach for cost-effective, holistic, rationalistic, and multi-targeted diabetes management.PMID:38115618 | DOI:10.2174/0113894501275731231215101426 (Source: Current Drug Targets)
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Shaheen Akhlaq Shabnam Anjum Ara Malik Itrat Mohammad Fazil Bilal Ahmad Usama Akram Merajul Haque Neelam Quddusi Ahmad Sayeed Source Type: research
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
Curr Drug Targets. 2023 Dec 19. doi: 10.2174/0113894501280380231214105255. Online ahead of print.ABSTRACTUveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor. Symptoms include blurred vision, redness of the eye, floaters, dark spots, a change in the size of the pupil, and loss of vision. The location, shape, and size of the tumor are important for therapeutic purposes. Treating me...
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Khalid Al Balushi Abdulrahman Al Hadhrami Hamdan Al Balushi Srijit Das Abdullah Al Lawati Source Type: research
An Exploratory Review on the Hypoglycemic Action of Unani Anti-diabetic Drugs via Possible Modulation of Gut Microbiota
CONCLUSION: This is the first study on the integrative strategy about the hypoglycemic effects of Unani herbs that could serve as a prerogative novel approach for cost-effective, holistic, rationalistic, and multi-targeted diabetes management.PMID:38115618 | DOI:10.2174/0113894501275731231215101426 (Source: Current Drug Targets)
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Shaheen Akhlaq Shabnam Anjum Ara Malik Itrat Mohammad Fazil Bilal Ahmad Usama Akram Merajul Haque Neelam Quddusi Ahmad Sayeed Source Type: research
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
Curr Drug Targets. 2023 Dec 19. doi: 10.2174/0113894501280380231214105255. Online ahead of print.ABSTRACTUveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor. Symptoms include blurred vision, redness of the eye, floaters, dark spots, a change in the size of the pupil, and loss of vision. The location, shape, and size of the tumor are important for therapeutic purposes. Treating me...
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Khalid Al Balushi Abdulrahman Al Hadhrami Hamdan Al Balushi Srijit Das Abdullah Al Lawati Source Type: research
An Exploratory Review on the Hypoglycemic Action of Unani Anti-diabetic Drugs via Possible Modulation of Gut Microbiota
CONCLUSION: This is the first study on the integrative strategy about the hypoglycemic effects of Unani herbs that could serve as a prerogative novel approach for cost-effective, holistic, rationalistic, and multi-targeted diabetes management.PMID:38115618 | DOI:10.2174/0113894501275731231215101426 (Source: Current Drug Targets)
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Shaheen Akhlaq Shabnam Anjum Ara Malik Itrat Mohammad Fazil Bilal Ahmad Usama Akram Merajul Haque Neelam Quddusi Ahmad Sayeed Source Type: research
Tebentafusp as a Promising Drug for the Treatment of Uveal Melanoma
Curr Drug Targets. 2023 Dec 19. doi: 10.2174/0113894501280380231214105255. Online ahead of print.ABSTRACTUveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor. Symptoms include blurred vision, redness of the eye, floaters, dark spots, a change in the size of the pupil, and loss of vision. The location, shape, and size of the tumor are important for therapeutic purposes. Treating me...
Source: Current Drug Targets - December 20, 2023 Category: Drugs & Pharmacology Authors: Khalid Al Balushi Abdulrahman Al Hadhrami Hamdan Al Balushi Srijit Das Abdullah Al Lawati Source Type: research
An Update on the Emerging Role of Wnt/ β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Curr Drug Targets. 2023 Dec 11. doi: 10.2174/0113894501276093231206064243. Online ahead of print.ABSTRACTRheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid a...
Source: Current Drug Targets - December 12, 2023 Category: Drugs & Pharmacology Authors: Pradyuman Prajapati Gaurav Doshi Source Type: research
An Update on the Emerging Role of Wnt/ β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Curr Drug Targets. 2023 Dec 11. doi: 10.2174/0113894501276093231206064243. Online ahead of print.ABSTRACTRheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid a...
Source: Current Drug Targets - December 12, 2023 Category: Drugs & Pharmacology Authors: Pradyuman Prajapati Gaurav Doshi Source Type: research
An Update on the Emerging Role of Wnt/ β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Curr Drug Targets. 2023 Dec 11. doi: 10.2174/0113894501276093231206064243. Online ahead of print.ABSTRACTRheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid a...
Source: Current Drug Targets - December 12, 2023 Category: Drugs & Pharmacology Authors: Pradyuman Prajapati Gaurav Doshi Source Type: research
An Update on the Emerging Role of Wnt/ β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Curr Drug Targets. 2023 Dec 11. doi: 10.2174/0113894501276093231206064243. Online ahead of print.ABSTRACTRheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid a...
Source: Current Drug Targets - December 12, 2023 Category: Drugs & Pharmacology Authors: Pradyuman Prajapati Gaurav Doshi Source Type: research
An Update on the Emerging Role of Wnt/ β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Curr Drug Targets. 2023 Dec 11. doi: 10.2174/0113894501276093231206064243. Online ahead of print.ABSTRACTRheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid a...
Source: Current Drug Targets - December 12, 2023 Category: Drugs & Pharmacology Authors: Pradyuman Prajapati Gaurav Doshi Source Type: research
An Update on the Emerging Role of Wnt/ β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis
Curr Drug Targets. 2023 Dec 11. doi: 10.2174/0113894501276093231206064243. Online ahead of print.ABSTRACTRheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid a...
Source: Current Drug Targets - December 12, 2023 Category: Drugs & Pharmacology Authors: Pradyuman Prajapati Gaurav Doshi Source Type: research
Recent Progress and Challenges in Clinical Translation of Nanomedicines in Diagnosis and Treatment of Lung Cancer
Curr Drug Targets. 2023 Dec 6. doi: 10.2174/0113894501273651231201061144. Online ahead of print.ABSTRACTLung cancer is one of the leading causes of death across the world. There are numerous challenges in the early diagnosis and effective treatment of lung cancer, including developing multidrug resistance. However, the diagnosis of lung cancer could be minimally invasive or non-invasive. Nowadays, nanomedicines offer solutions to several emerging challenges in drug delivery research areas. It has the potential to enhance the therapeutic efficacy of biologically and chemically active agents at the site of action. This appro...
Source: Current Drug Targets - December 7, 2023 Category: Drugs & Pharmacology Authors: Bhavna Yadav Mahima Chauhan Rahul Pratap Singh None Sonali Saurabh Shekhar Source Type: research
